The global thrombosis drugs market is witnessing strong growth due to the increasing prevalence of cardiovascular disorders, deep vein thrombosis, pulmonary embolism, and atrial fibrillation worldwide. Technological advancements in anticoagulant therapies, coupled with growing awareness regarding thrombotic disorders, are significantly contributing to market expansion. Pharmaceutical companies...